Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Stroke. 2010 Feb 11;41(4):790–797. doi: 10.1161/STROKEAHA.109.569616

Figure 4.

Figure 4

(A) Gelatin zymography showing gelatinolytic activity of MMP-2 (68-kDa: latent form; 62-kDa: cleaved form) and MMP-9 (98- and 105-kDa: latent form; 90-kDa: cleaved form). APMA: chemical activator for MMP-9. (B) Relative optical density of MMP-2 (68-kDa) and MMP-9 (98-kDa) against respective standard. n=6 in each group. *p<0.05 vs respective control mice. †p<0.05 vs respective chronic HT mice. §p<0.05 vs respective chronic/acute HT mice without ICH. #p<0.05. N.S.: not significant.